Cvs Pharmacy #06999 | |
550 Lancaster Ave, Berwyn, Pennsylvania 19312 | |
(610) 644-7192 |
Name | Cvs Pharmacy #06999 |
---|---|
Organization Name | Pennsylvania Cvs Pharmacy, L.l.c. |
Location | 550 Lancaster Ave, Berwyn, Pennsylvania 19312 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (610) 644-7192 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Those who suffer from common functional gastrointestinal disorders face work productivity losses and impairments in daily activity that amount to the loss of at least one day of work in a 40-hour workweek, according to a new study presented at the Annual Scientific Meeting of the American College of Gastroenterology.
Especially in settings where personal protective equipment, or PPE, is in short supply, intubation - inserting a breathing tube down a patient's throat - poses a major risk of SARS-CoV-2 exposure for doctors and nurses as viral particles are released into the air.
A new preprint research paper posted to the bioRxiv* server describes the results of a nuclear magnetic resonance (NMR) study to determine the structure of the S protein transmembrane domain (TMD) and its membrane-proximal regions.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 8 days ago
NPI Number | 1366546152 |
Organization Name | PENNSYLVANIA CVS PHARMACY, L.L.C. |
Doing Business As | CVS PHARMACY #06999 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 550 Lancaster Ave, Berwyn, PA 19312 |
Phone Number | 610-644-7192 |
News Archive
Those who suffer from common functional gastrointestinal disorders face work productivity losses and impairments in daily activity that amount to the loss of at least one day of work in a 40-hour workweek, according to a new study presented at the Annual Scientific Meeting of the American College of Gastroenterology.
Especially in settings where personal protective equipment, or PPE, is in short supply, intubation - inserting a breathing tube down a patient's throat - poses a major risk of SARS-CoV-2 exposure for doctors and nurses as viral particles are released into the air.
A new preprint research paper posted to the bioRxiv* server describes the results of a nuclear magnetic resonance (NMR) study to determine the structure of the S protein transmembrane domain (TMD) and its membrane-proximal regions.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 8 days ago
News Archive
Those who suffer from common functional gastrointestinal disorders face work productivity losses and impairments in daily activity that amount to the loss of at least one day of work in a 40-hour workweek, according to a new study presented at the Annual Scientific Meeting of the American College of Gastroenterology.
Especially in settings where personal protective equipment, or PPE, is in short supply, intubation - inserting a breathing tube down a patient's throat - poses a major risk of SARS-CoV-2 exposure for doctors and nurses as viral particles are released into the air.
A new preprint research paper posted to the bioRxiv* server describes the results of a nuclear magnetic resonance (NMR) study to determine the structure of the S protein transmembrane domain (TMD) and its membrane-proximal regions.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 8 days ago
Cvs Pharmacy #06999 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 550 Lancaster Ave, Berwyn, Pennsylvania 19312 Phone: (610) 644-7192 | |
Prospecs Type: Eyewear Supplier (Equipment, not the service) Location: 1175 Lancaster Ave, Berwyn, Pennsylvania 19312 Phone: (610) 384-9100 |